Study on the Regulation Effect of Optogenetic Technology on LFP of the Basal Ganglia Nucleus in Rotenone-Treated Rats
Background. Parkinson’s disease (PD) is a common neurological degenerative disease that cannot be completely cured, although drugs can improve or alleviate its symptoms. Optogenetic technology, which stimulates or inhibits neurons with excellent spatial and temporal resolution, provides a new idea a...
Saved in:
Main Authors: | Zongya Zhao, Yanxiang Niu, Peiqi Chen, Yu Zhu, Liangliang Shi, Xuewei Zhao, Chang Wang, Yehong Zhang, Zhixian Gao, Wenshuai Jiang, Wu Ren, Renjun Gu, Yi Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Neural Plasticity |
Online Access: | http://dx.doi.org/10.1155/2021/9938566 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modeling the modulation of beta oscillations in the basal ganglia by dual-target optogenetic stimulation
by: Xiaomin Wang, et al.
Published: (2025-01-01) -
Role of the Basal Ganglia in Balance Control
by: Jasper E. Visser, et al.
Published: (2005-01-01) -
Basal Ganglia Disease and Visuospatial Cognition: Are There Disease-Specific Impairments?
by: Erich Mohr, et al.
Published: (1997-01-01) -
Interaction of Indirect and Hyperdirect Pathways on Synchrony and Tremor-Related Oscillation in the Basal Ganglia
by: Xia Shi, et al.
Published: (2021-01-01) -
Chorea Hyperglycemia Basal Ganglia Syndrome in a 63-Year-Old Male
by: Michael Sperling, et al.
Published: (2018-01-01)